
Recent developments with Mereo Biopharma Group Plc ADR (MREO) have led to the company’s beta value being reach 0.46 cents.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) on Monday, soared 6.83% from the previous trading day, before settling in for the closing price of $1.61.